| 國立成功大學 |
2023-12 |
Clinical implications of PNA-sequencing as a complementary test for EGFR mutation analysis in human lung cancer
|
Chen;Yi-Lin;Lin;Chien-Chung;Yu;Yu-Ting;Chen;Wan-Li;Yang;Shu-Ching;Huang;Wenya;Su;Wu-Chou;Chow;Nan-Haw;Ho;Chung-Liang |
| 國立成功大學 |
2023-11-2 |
Distinct Features of Plasma Ultrashort Single-Stranded Cell-Free DNA as Biomarkers for Lung Cancer Detection
|
Cheng;Jordan;Swarup;Neeti;Li;Feng;Kordi;Misagh;Lin;Chien-Chung;Yang;Szu-Chun;Huang;Wei-Lun;Aziz;Mohammad;Kim;Yong;Chia;David;Yeh;Yu-Min;Wei;Fang;Zheng;David;Zhang;Liying;Pellegrini;Matteo;Su;Wu-Chou;Wong;David, T. W. |
| 國立成功大學 |
2023-06-23 |
Concise nanotherapeutic modality for cancer involving graphene oxide dots in conjunction with ascorbic acid
|
Shih;Chun-Yan;Wang;Pei-Ting;Chung;Wei-Pang;Wang;Wen-Hsiu;Chiang;I-Ting;Su;Wu-Chou;Huang;Wei-Lun;Teng;Hsisheng |
| 國立成功大學 |
2023-03-9 |
Effect of BIM expression on the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs
|
Chu;Chang-Yao;Lin;Chien-Yu;Lin;Chien-Chung;Li;Chien-Feng;Wu;Shang-Yin;Tsai;Jeng-Shiuan;Yang;Szu-Chun;Chen;Chian-Wei;Lin;Chia-Yin;Chang;Chao-Chun;Yen;Yi-Ting;Tseng;Yau-Lin;Su;Po-Lan;Su;Wu-Chou |
| 國立成功大學 |
2022-11 |
Pembrolizumab and Chemotherapy Combination Prolonged Progression-Free Survival in Patients with NSCLC with High PD-L1 Expression and Low Neutrophil-to-Lymphocyte Ratio
|
Tsai;Jeng-Shiuan;Wei;Sheng-Huan;Chen;Chian-Wei;Yang;Szu-Chun;Tseng;Yau-Lin;Su;Po-Lan;Lin;Chien-Chung;Su;Wu-Chou |
| 國立成功大學 |
2022-08-11 |
Iron oxide@chlorophyll clustered nanoparticles eliminate bladder cancer by photodynamic immunotherapy-initiated ferroptosis and immunostimulation
|
Chin;Yu-Cheng;Yang;Li-Xing;Hsu;Fei-Ting;Hsu;Che-Wei;Chang;Te-Wei;Chen;Hsi-Ying;Chen;Linda, Yen-Chien;Chia;Chun, Zi;Hung;Chun-Hua;Su;Wu-Chou;Chiu;Yi-Chun;Huang;Chih-Chia;Liao;Mei-Yi |
| 國立成功大學 |
2022-08 |
Development of a cancer cells self-activating and miR-125a-5p expressing poly-pharmacological nanodrug for cancer treatment
|
Chang;Yung-Chieh;Shieh;Min-Chieh;Chang;Yen-Hsuan;Huang;Wei-Lun;Su;Wu-Chou;Cheng;Fong-Yu;Cheung;Antonio, Chun Hei |
| 國立成功大學 |
2022-05-20 |
Economic Analysis of Tissue-First, Plasma-First, and Complementary NGS Approaches for Treatment-Naive Metastatic Lung Adenocarcinoma
|
Yang;Szu-Chun;Lin;Chien-Chung;Chen;Yi-Lin;Su;Wu-Chou |
| 國立成功大學 |
2022-02-28 |
The impact of driver mutation on the treatment outcome of early-stage lung cancer patients receiving neoadjuvant immunotherapy and chemotherapy
|
Su;Po-Lan;Chen;Jung-Yueh;Chu;Chang-Yao;Chen;Yi-Lin;Chen;Wan-Li;Lin;Kuan-Yu;Ho;Chung-Liang;Tsai;Jeng-Shiuan;Yang;Szu-Chun;Chen;Chian-Wei;Wu;Yi-Lin;Tseng;Yau-Lin;Chang;Chao-Chun;Yen;Yi-Ting;Lin;Chia-Ying;Lin;Chien-Chung;Su;Wu-Chou |
| 國立成功大學 |
2022-01-7 |
FTY720 in resistant human epidermal growth factor receptor 2-positive breast cancer
|
Chung;Wei-Pang;Huang;Wei-Lun;Liao;Wei-An;Hung;Chun-Hua;Chiang;Chi-Wu;Cheung;Antonio, Chun Hei;Su;Wu-Chou |
| 國立成功大學 |
2022-01 |
Improved survival in patients with unresectable stage III EGFR-mutant adenocarcinoma with upfront EGFR-tyrosine kinase inhibitors
|
Wang;Sheng-Yuan;Lai;Ching-Han;Chen;Chian-Wei;Yang;Szu-Chun;Chang;Chao-Chun;Lin;Chia-Ying;Yen;Yi-Ting;Tseng;Yau-Lin;Su;Po-Lan;Lin;Chien-Chung;Su;Wu-Chou |
| 國立成功大學 |
2022 |
PI3K inhibitors in trastuzumab-resistant HER2-positive breast cancer cells with PI3K pathway alterations
|
Chung;Wei-Pang;Huang;Wei-Lun;Lee;Chun-Hui;Hsu;Hui-Ping;Huang;Wan-Ling;Liu;You-Yu;Su;Wu-Chou |
| 國立成功大學 |
2022 |
Targeting protumor factor chitinase-3-like-1 secreted by Rab37 vesicles for cancer immunotherapy
|
Yang;Pei-Shan;Yu;Min-Hua;Hou;Ya-Chin;Chang;Chih-Peng;Lin;Shao-Chieh;Kuo;I-Ying;Su;Pei-Chia;Cheng;Hung-Chi;Su;Wu-Chou;Shan;Yan-Shen;Wang;Yi-Ching |
| 國立成功大學 |
2021-12 |
Association between Altered Oncogenic Signaling Pathways and Overall Survival of Patients with Metastatic Colorectal Cancer
|
Huang;Yi-Hsuan;Lin;Peng-Chan;Su;Wu-Chou;Chan;Ren-Hao;Chen;Po-Chuan;Lin;Bo-Wen;Shen;Meng-Ru;Chen;Shang-Hung;Yeh;Yu-Min |
| 國立成功大學 |
2021-11 |
CD40 Pathway and IL-2 Expression Mediate the Differential Outcome of Colorectal Cancer Patients with Different CSF1R c.1085 Genotypes
|
Yeh;Yu-Min;Lin;Peng-Chan;Su;Wu-Chou;Shen;Meng-Ru |
| 國立成功大學 |
2021-09-24 |
Development of a novel ALK rearrangement screening test for non-small cell lung cancers
|
Chen;Yi-Lin;Chen;Wan-Li;Cheng;Yi-Chia;Lin;Ming-Ching;Yang;Shu-Ching;Tsai;Hung-Wen;Lin;Chien-Chung;Su;Wu-Chou;Chow;Nan-Haw;Ho;Chung-Liang |
| 國立成功大學 |
2021-09 |
EGFR-TKI plus bevacizumab versus EGFR-TKI monotherapy for patients with EGFR mutation-positive advanced non-small cell lung cancer-A propensity score matching analysis
|
Tsai;Jeng-Shiuan;Su;Po-Lan;Yang;Szu-Chun;Chang;Chao-Chun;Lin;Chia-Ying;Yen;Yi-Ting;Tseng;Yau-Lin;Lai;Wu-Wei;Lin;Chien-Chung;Su;Wu-Chou |
| 國立成功大學 |
2021-05-14 |
Biocompatible hole scavenger-assisted graphene oxide dots for photodynamic cancer therapy
|
Shih;Chun-Yan;Huang;Wei-Lun;Chiang;I-Ting;Su;Wu-Chou;Teng;Hsisheng |
| 國立成功大學 |
2021-04 |
Development of the CK-MB-1 trastuzumab-resistant HER2-positive breast cancer cell line and xenograft animal models
|
Chung;Wei-Pang;Huang;Wei-Lun;Liao;Wei-An;Huang;Wan-Ling;Liu;You-Yu;Su;Wu-Chou |
| 國立成功大學 |
2021-03-1 |
Phase I dose escalation study of sorafenib plus S-1 for advanced solid tumors
|
Tsai;Hui-Jen;Shiah;Her-Shyong;Chang;Jang-Yang;Su;Wu-Chou;Chiang;Nai-Jung;Chen;Li-Tzong |
| 國立成功大學 |
2021-03 |
Extracellular Vesicle miR-200c Enhances Gefitinib Sensitivity in Heterogeneous EGFR-Mutant NSCLC
|
Lin;Chien-Chung;Wu;Chin-You;Tseng;Joseph, Ta-Chien;Hung;Chun-Hua;Wu;Shang-Yin;Huang;Yu-Ting;Chang;Wei-Yuan;Su;Po-Lan;Su;Wu-Chou |
| 國立成功大學 |
2021-02 |
First-line treatment with irreversible tyrosine kinase inhibitors associated with longer OS in EGFR mutation-positive non-small cell lung cancer
|
Su;Po-Lan;Chen;Chian-Wei;Wu;Yi-Lin;Lin;Chien-Chung;Su;Wu-Chou |
| 國立成功大學 |
2021-02 |
Nanomedicine-Based Strategies Assisting Photodynamic Therapy for Hypoxic Tumors: State-of-the-Art Approaches and Emerging Trends
|
Shih;Chun-Yan;Wang;Pei-Ting;Su;Wu-Chou;Teng;Hsisheng;Huang;Wei-Lun |
| 國立成功大學 |
2021 |
Converged Rab37/IL-6 trafficking and STAT3/PD-1 transcription axes elicit an immunosuppressive lung tumor microenvironment
|
Kuo;I-Ying;Yang;You-En;Yang;Pei-Shan;Tsai;Yu-Jou;Tzeng;Hong-Tai;Cheng;Hung-Chi;Kuo;Wan-Ting;Su;Wu-Chou;Chang;Chih-Peng;Wang;Yi-Ching |
| 國立成功大學 |
2020-10 |
Clinical Frailty Scale in Predicting Postoperative Outcomes in Older Patients Undergoing Curative Surgery for Urologic Malignancies: A Prospective Observational Cohort Study
|
Sun;Chien-Yao;Huang;Chien-Cheng;Tsai;Yuh-Shyan;Chang;Yu-Tzu;Ou;Chien-Hui;Su;Wu-Chou;Fan;Sheng-Yu;Wang;Shan-Tair;Yang;Deng-Chi;Huang;Chi-Chang;Chang;Chia-Ming |
| 國立成功大學 |
2020-08 |
Ultra-Short Circulating Tumor DNA (usctDNA) in Plasma and Saliva of Non-Small Cell Lung Cancer (NSCLC) Patients
|
Li;Feng;Wei;Fang;Huang;Wei-Lun;Lin;Chien-Chung;Li;Liang;Shen;Macy, Macy M.;Yan;Qingxiang;Liao;Wei;Chia;David;Tu;Michael;Tang;Jason, H.;Feng;Ziding;Kim;Yong;Su;Wu-Chou;Wong;David, T. W. |
| 國立成功大學 |
2020-07-16 |
Immune Checkpoint Inhibitor-Induced Myasthenia Gravis
|
Huang;Yi-Te;Chen;Ya-Ping;Lin;Wen-Chih;Su;Wu-Chou;Sun;Yuan-Ting |
| 國立成功大學 |
2020-07 |
Assessment of Serological Early Biomarker Candidates for Lung Adenocarcinoma by using Multiple Reaction Monitoring-Mass Spectrometry
|
Wu;Hsin-Yi;Pan;Yu-Yi;Kopylov;Arthur, T.;Zgoda;Victor;Ma;Mi-Chia;Wang;Ching-Hsun;Su;Wu-Chou;Lai;Wu-Wei;Cheng;Pin-Nan;Liao;Pao-Chi |
| 國立成功大學 |
2020-05-14 |
Silver-coated zero-valent iron nanoparticles enhance cancer therapy in mice through lysosome-dependent dual programed cell death pathways: triggering simultaneous apoptosis and autophagy only in cancerous cells
|
Yang;Li-Xing;Wu;Ya-Na;Wang;Pei-Wen;Huang;Kuang-Jing;Su;Wu-Chou;Shieh;Dar-Bin |
| 國立成功大學 |
2020-04-8 |
Comparative effectiveness and cost-effectiveness of three first-line EGFR-tyrosine kinase inhibitors: Analysis of real-world data in a tertiary hospital in Taiwan
|
Yang;Szu-Chun;Lai;Wu-Wei;Hsu;Jason, C.;Su;Wu-Chou;Wang;Jung-Der |
| 國立成功大學 |
2019-11 |
Dynamic Changes of Health Utility in Lung Cancer Patients Receiving Different Treatments: A 7-Year Follow-up
|
Yang;Szu-Chun;Kuo;Chin-Wei;Lai;Wu-Wei;Lin;Chien-Chung;Su;Wu-Chou;Chang;Sheng-Mao;Wang;Jung-Der |
| 國立成功大學 |
2019-10 |
Real-world outcomes of NSCLC patients receiving tissue or circulating tumor DNA-guided osimertinib treatment
|
Su;Po-Lan;Yang;Szu-Chun;Chen;Yi-Lin;Wu;Yi-Lin;Lin;Chia-Ying;Chang;Wei-Yuan;Tseng;Yau-Lin;Lai;Wu-Wei;Ho;Chung-Liang;Lin;Chien-Chung;Su;Wu-Chou |
| 國立成功大學 |
2019-09-2 |
Iron Release Profile of Silica-Modified Zero-Valent Iron NPs and Their Implication in Cancer Therapy
|
Yang;Li-Xing;Wu;Ya-Na;Wang;Pei-Wen;Su;Wu-Chou;Shieh;Dar-Bin |
| 國立成功大學 |
2019-08 |
Brain MRI imaging characteristics predict treatment response and outcome in patients with de novo brain metastasis of EGFR-mutated NSCLC
|
Lin;Chia-Ying;Chang;Chao-Chun;Su;Po-Lan;Lin;Chien-Chung;Tseng;Yau-Lin;Su;Wu-Chou;Yen;Yi-Ting |
| 國立成功大學 |
2019-07-16 |
Five Technologies for Detecting the EGFR T790M Mutation in the Circulating Cell-Free DNA of Patients With Non-small Cell Lung Cancer: A Comparison
|
Chen;Yi-Lin;Lin;Chien-Chung;Yang;Shu-Ching;Chen;Wan-Li;Chen;Jian-Rong;Hou;Yi-Hsin;Lu;Cheng-Chan;Chow;Nan-Haw;Su;Wu-Chou;Ho;Chung-Liang |
| 國立成功大學 |
2019-03 |
Prognostic value of volumetric metabolic parameter changes determined by during and after radiotherapy-based F-18-FDG PET/CT in stage Ill non-small cell lung cancer
|
Chen;Helen, Helen H. W.;Su;Wu-Chou;Guo;How-Ran;Lee;Bi-Fang;Chiu;Nan-Tsing |
| 國立成功大學 |
2019-01 |
Psychometric evaluation of the WHOQOL-BREF, Taiwan version, across five kinds of Taiwanese cancer survivors: Rasch analysis and confirmatory factor analysis
|
Lin;Chung-Ying;Hwang;Jing-Shiang;Wang;Wen-Chung;Lai;Wu-Wei;Su;Wu-Chou;Wu;Tzu-Yi;Yao;Grace;Wang;Jung-Der |
| 國立成功大學 |
2018-11 |
Different pattern of PD-L1, IDO, and FOXP3 Tregs expression with survival in thymoma and thymic carcinoma
|
Wei;Yu-Feng;Chu;Chang-Yao;Chang;Chao-Chun;Lin;Sheng-Hsiang;Su;Wu-Chou;Tseng;Yau-Lin;Lin;Chien-Chung;Yen;Yi-Ting |
| 國立成功大學 |
2018-11 |
Electric Field-Induced Release and Measurement Liquid Biopsy for Noninvasive Early Lung Cancer Assessment
|
Wei;Fang;Strom;Charles, M.;Cheng;Jordan;Lin;-Chung, Chien;Hsu;Ching-Yun;Hoo;Soo, Guy W.;Chia;David;Kim;Yong;Li;Feng;Elashoff;David;Grognan;Tristan;Tu;Michael;Liao;Wei;Xian;Rena;Grody;Wayne, Wayne W.;Su;Wu-Chou;Wong;David, T. W. |
| 國立成功大學 |
2018-10-1 |
Rab37 in lung cancer mediates exocytosis of soluble ST2 and thus skews macrophages toward tumor-suppressing phenotype
|
Tzeng;Hong-Tai;Su;Ching-Chin;Chang;Chih-Peng;Lai;Wu-Wei;Su;Wu-Chou;Wang;Yi-Ching |
| 國立成功大學 |
2018-09-25 |
Preventing and treating brain metastases with three first-line EGFR-tyrosine kinase inhibitors in patients with EGFR mutation-positive advanced non-small cell lung cancer
|
Su;Po-Lan;Wu;Yi-Lin;Chang;Wei-Yuan;Ho;Chung-Liang;Tseng;Yau-Lin;Lai;Wu-Wei;Su;Wu-Chou;Lin;Chien-Chung;Yang;Szu-Chun |
| 國立成功大學 |
2018-09-12 |
Autophagy regulates vinorelbine sensitivity due to continued Keap1-mediated ROS generation in lung adenocarcinoma cells
|
Wu;Yan-Wei;Lin;Chiou-Feng;Lin;Yee-Shin;Su;Wu-Chou;Chiu;Wei-Hsin |
| 國立成功大學 |
2018-08-29 |
Rab37 mediates exocytosis of secreted frizzled-related protein 1 to inhibit Wnt signaling and thus suppress lung cancer stemness
|
Cho;Shu-Huei;Kuo;I-Ying;Lu;Frank, Pei-Jung;Tzeng;Hong-Tai;Lai;Wu-Wei;Su;Wu-Chou;Wang;Yi-Ching |
| 國立成功大學 |
2018-06 |
Excellent treatment response with pembrolizumab in a lung cancer patient who developed immune-mediated acute motor/sensory axonal polyneuropathy
|
Yen;Chih-Chieh;Su;Hui-Chen;Chu;Chang-Yao;Lai;Shi-Jie;Yan;Jing-Jou;Su;Wen-Pin;Su;Wu-Chou |
| 國立成功大學 |
2018-02-5 |
Dynamic changes in quality of life after three first-line therapies for EGFR mutation-positive advanced non-small-cell lung cancer
|
Yang;Szu-Chun;Lin;Chien-Chung;Lai;Wu-Wei;Chang;Sheng-Mao;Hwang;Jing-Shiang;Su;Wu-Chou;Wang;Jung-Der |
| 國立成功大學 |
2018-02-15 |
The impact of EGFR mutations on the incidence and survival of stages I to III NSCLC patients with subsequent brain metastasis
|
Chang;Wei-Yuan;Wu;Yi-Lin;Su;Po-Lan;Yang;Szu-Chun;Lin;Chien-Chung;Su;Wu-Chou |
| 國立成功大學 |
2017-11 |
Bimetallic nanoplasmonic gap-mode SERS substrate for lung normal and cancer-derived exosomes detection
|
Sivashanmugan;Kundan;Huang;Wei-Lun;Lin;Chen-Hsueh;Liao;Jiunn-Der;Lin;Chien-Chung;Su;Wu-Chou;Wen;Ten-Chin |
| 國立成功大學 |
2017-10-15 |
The c.1085A > G Genetic Variant of CSF1R Gene Regulates Tumor Immunity by Altering the Proliferation, Polarization, and Function of Macrophages
|
Yeh;Yu-Min;Hsu;Shan-Ju;Lin;Peng-Chan;Hsu;Keng-Fu;Wu;Pei-Ying;Su;Wu-Chou;Chang;Jang-Yang;Shen;Meng-Ru |
| 國立成功大學 |
2017-03-14 |
Liquid biopsy genotyping in lung cancer: ready for clinical utility?
|
Huang;Wei-Lun;Chen;Yi-Lin;Yang;Szu-Chun;Ho;Chung-Liang;Wei;Fang;Wong;David, T.;Su;Wu-Chou;Lin;Chien-Chung |
